Since we identified that ABCG1 can phosphorylate AKT2 in ovarian cancer, given the poor curative effects of ovarian cancer, the kinase role of ABCG1 may provide a therapeutic target for ovarian tumorigenesis after further investigations. This evidence concerns the gene AKT2 and ovarian carcinoma.